PCM
NERV icon

Pinz Capital Management’s Minerva Neurosciences NERV Stock Holding History

Pinz Capital Management’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-988
Closed -$18K – 306
2021
Q2 		$18K Buy
+988
New +$21.3K 0.01% 381

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pinz Capital Management's NERV Position: Q3 2021 in Review

Pinz Capital Management sold out of Minerva Neurosciences (NERV) in Q3 2021, closing a stake of 988 shares — an estimated $18K sold.

Pinz Capital Management first reported a position in NERV in Q2 2021 and held it in 1 quarter. The position peaked at $18K in Q2 2021. 46 funds tracked by Wall St. Rank hold NERV as of Q3 2021.

  • Pinz Capital Management reported no remaining Minerva Neurosciences position as of Q3 2021 after selling out during the quarter.
  • Pinz Capital Management sold 988 Minerva Neurosciences shares in Q3 2021, an estimated $18K.
  • Pinz Capital Management first reported a position in Minerva Neurosciences in Q2 2021 and held it in 1 quarter.
  • Pinz Capital Management's Minerva Neurosciences position peaked at $18K in Q2 2021.
  • 46 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q3 2021.

Based on Pinz Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.